AstraZeneca Sells Seroquel and Seroquel XR Rights in Europe, Russia

Date : 10/30/2019 @ 7:47AM
Source : Dow Jones News
Stock : Astrazeneca Plc (AZN)
Quote : 7878.0  171.0 (2.22%) @ 4:35PM
Astrazeneca share price Chart

AstraZeneca Sells Seroquel and Seroquel XR Rights in Europe, Russia

Astrazeneca (LSE:AZN)
Historical Stock Chart

3 Months : From Oct 2019 to Jan 2020

Click Here for more Astrazeneca Charts.
   By Adria Calatayud 

AstraZeneca PLC (AZN.LN) said Wednesday that it has agreed to sell and license commercial rights to its Seroquel and Seroquel XR drugs in Europe and Russia to Cheplapharm Arzneimittel GmbH for up to $239 million.

The company said Cheplapharm will make an initial payment of $178 million and might make a further payment of up to $61 million subject to future sales, the U.K. pharmaceutical company said.

AstraZeneca said the deal will allow it to focus on its main therapy areas. The company had previously sold rights to the drugs in the U.K., Japan and other major international markets.

AstraZeneca will continue to manufacture and supply Seroquel and Seroquel XR--anti-psychotic medicines with antidepressant properties--to Cheplapharm during a transition period,

For 2018, pretax profit attributable to the drugs in Europe and Russia was $86 million, AstraZeneca said.


Write to Adria Calatayud at


(END) Dow Jones Newswires

October 30, 2019 03:32 ET (07:32 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200117 20:30:26